NO20024011L - Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret - Google Patents

Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret

Info

Publication number: NO20024011L
Authority: NO; Norway
Prior art keywords: prebiotic; aid; improve; immune system; enhancing
Prior art date: 2000-03-01

Application number

NO20024011A

Other languages

English (en)

Norwegian (no)

Other versions

NO20024011D0 (no

Inventor

Ferdinand Haschke

Anne-Lise Carrie

Zdenek Kratky

Harriet Link-Amster

Florence Rochat

Original Assignee

Nestle Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-01

Filing date

2002-08-22

Publication date

2002-08-22

2002-08-22 Application filed by Nestle Sa filed Critical Nestle Sa

2002-08-22 Publication of NO20024011L publication Critical patent/NO20024011L/no

2002-08-22 Publication of NO20024011D0 publication Critical patent/NO20024011D0/no

Links

235000013406 prebiotics Nutrition 0.000 title abstract 7
239000000203 mixture Substances 0.000 title abstract 4
150000001720 carbohydrates Chemical class 0.000 title 1
238000009472 formulation Methods 0.000 title 1
210000000987 immune system Anatomy 0.000 title 1
230000002708 enhancing effect Effects 0.000 abstract 4
230000028993 immune response Effects 0.000 abstract 4
235000016709 nutrition Nutrition 0.000 abstract 3
201000005505 Measles Diseases 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
238000004519 manufacturing process Methods 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 abstract 1
229940107187 fructooligosaccharide Drugs 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Dermatology (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Mycology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Dairy Products (AREA)
Confectionery (AREA)
Grain Derivatives (AREA)
Jellies, Jams, And Syrups (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20024011A 2000-03-01 2002-08-22 Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret NO20024011D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00200735		2000-03-01
PCT/EP2001/001627 WO2001064225A1 (fr)	2000-03-01	2001-02-14	Formulation de carbohydrate (adjuvant prebiotique) destine a augmenter une reponse immune

Publications (2)

Publication Number	Publication Date
NO20024011L true NO20024011L (no)	2002-08-22
NO20024011D0 NO20024011D0 (no)	2002-08-22

Family

ID=8171132

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20024011A NO20024011D0 (no)	2000-03-01	2002-08-22	Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret

Country Status (21)

Country	Link
US (2)	US20030040492A1 (fr)
EP (1)	EP1261355B1 (fr)
JP (1)	JP4838477B2 (fr)
KR (1)	KR20020081375A (fr)
CN (1)	CN1243551C (fr)
AR (1)	AR027968A1 (fr)
AT (1)	ATE283697T1 (fr)
AU (2)	AU2001231746C1 (fr)
BR (1)	BR0108828A (fr)
CA (1)	CA2400969C (fr)
DE (1)	DE60107544T2 (fr)
ES (1)	ES2232591T3 (fr)
HU (1)	HUP0204546A3 (fr)
IL (1)	IL151280A0 (fr)
MX (1)	MXPA02008447A (fr)
NO (1)	NO20024011D0 (fr)
PL (1)	PL365136A1 (fr)
PT (1)	PT1261355E (fr)
UA (1)	UA73763C2 (fr)
WO (1)	WO2001064225A1 (fr)
ZA (1)	ZA200207849B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7029702B2 (en) *	1998-07-07	2006-04-18	Ritter Natural Sciences Llc	Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6319252B1 (en)	1999-07-23	2001-11-20	Mcdevitt Dennis	System and method for attaching soft tissue to bone
KR20020043078A (ko) *	2000-12-01	2002-06-08	한인규	올리고당이 포함된 복합생균제
GB0229015D0 (en)	2002-12-12	2003-01-15	Novartis Nutrition Ag	New Compound
ES2416287T3 (es) *	2003-06-23	2013-07-31	Nestec S.A.	Empleo de una fórmula nutritiva para la función óptima de la barrera intestinal
US20050118299A1 (en) *	2003-12-01	2005-06-02	The Iams Company	Companion animal compositions comprising short chain oligofructose
US20050118234A1 (en) *	2003-12-01	2005-06-02	The Iams Company	Methods and kits related to administration of a fructooligosaccharide
US20050119222A1 (en)	2003-12-01	2005-06-02	The Iams Company	Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
NO320546B1 (no) *	2003-12-12	2005-12-19	Nova Biotics As	Prebiotiske kombinasjonsprodukter
US20080126195A1 (en) *	2004-07-22	2008-05-29	Ritter Andrew J	Methods and Compositions for Treating Lactose Intolerance
US7572474B2 (en) *	2005-06-01	2009-08-11	Mead Johnson Nutrition Company	Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8287931B2 (en) *	2005-06-30	2012-10-16	Mead Johnson Nutrition Company	Nutritional composition to promote healthy development and growth
US8075934B2 (en) *	2008-10-24	2011-12-13	Mead Johnson Nutrition Company	Nutritional composition with improved digestibility
JP4889262B2 (ja) *	2005-08-19	2012-03-07	理研ビタミン株式会社	脂溶性薬剤組成物
US20080003329A1 (en) *	2006-06-30	2008-01-03	Ricardo Rueda	Enriched infant formulas
WO2008046625A2 (fr) *	2006-10-18	2008-04-24	Dsm Ip Assets B.V.	Encapsulation de substances sensibles à la chaleur et à l'humidité
DE102007008664B4 (de) *	2007-02-20	2021-07-29	Vitacare Gmbh & Co. Kg	Mittel zur Anwendung bei Fructoseintoleranz
WO2009027039A1 (fr) *	2007-08-24	2009-03-05	Barry Callebaut Ag	Procédé et confiserie produite par un tel procédé
US20110223248A1 (en) *	2007-12-12	2011-09-15	Ritter Pharmaceuticals, Inc.	Methods and compositions for treating lactose intolerance
HUE028390T2 (en)	2008-06-13	2016-12-28	Nutricia Nv	Nutrition to prevent infections
WO2010008491A2 (fr) *	2008-06-25	2010-01-21	Ritter Natural Sciences, Llc	Compositions de lactose ayant une teneur réduite en lactose
US8986769B2 (en) *	2008-10-24	2015-03-24	Mead Johnson Nutrition Company	Methods for preserving endogenous TGF-β
US8425955B2 (en) *	2009-02-12	2013-04-23	Mead Johnson Nutrition Company	Nutritional composition with prebiotic component
SG173832A1 (en)	2009-02-24	2011-09-29	Ritter Pharmaceuticals Inc	Prebiotic formulations and methods of use
US8293264B2 (en) *	2009-05-11	2012-10-23	Mead Johnson Nutrition Company	Nutritional composition to promote healthy development and growth
WO2010143940A1 (fr)	2009-06-12	2010-12-16	N.V. Nutricia	Mélange synergique de bêta-galacto-oligosaccharides avec des liaisons bêta-1,3 et bêta-1,4/1,6
EP3342413B1 (fr)	2009-07-15	2021-10-20	N.V. Nutricia	Fucosyllactose oligosaccharide non digestible identique à celui du lait maternel pour le traitement et/ou la prévention de la diarrhée virale
US20120178674A1 (en)	2009-07-15	2012-07-12	N.V. Nutricia	Mixture of non-digestible oligosaccharides for stimulating the immune system
PH12012500687A1 (en)	2009-11-12	2012-10-29	Nestec Sa	Nutritional composition for promoting gut microbiota balance and health
WO2011137249A1 (fr)	2010-04-28	2011-11-03	Ritter Pharmaceuticals, Inc.	Formulations prébiotiques et méthodes d'utilisation
US20110293784A1 (en)	2010-05-28	2011-12-01	Anja Wittke	Milk-based nutritional compositions
NL2007268C2 (en)	2011-08-16	2013-02-19	Friesland Brands Bv	Nutritional compositions comprising human milk oligosaccharides and uses thereof.
US20150086587A1 (en) *	2012-03-28	2015-03-26	Kansas State University Research Foundation	Vaccine adjuvant
WO2013187755A1 (fr)	2012-06-14	2013-12-19	N.V. Nutricia	Formule fermentée avec oligosaccharides non digestibles pour nourrissons
CN103330935A (zh) *	2013-06-17	2013-10-02	中山大学	果糖作为疫苗佐剂的应用
RU2663065C2 (ru)	2013-11-04	2018-08-01	Н.В. Нютрисиа	Ферментированное детское питание с неперевариваемыми олигосахаридами
EA035945B1 (ru) *	2015-08-04	2020-09-04	Зюдцукер АГ	Профилактическое использование инулина от синусита
WO2019031961A1 (fr)	2017-08-11	2019-02-14	N.V. Nutricia	Oligosaccharide de lait humain pour améliorer la condition physique immunitaire
CN111148531A (zh)	2017-09-08	2020-05-12	伊夫罗生物科学公司	细菌胞外囊泡
KR20200053532A (ko) *	2017-09-08	2020-05-18	에벨로 바이오사이언시즈, 인크.	프레보텔라로부터의 세포외 소포
JP7469037B2 (ja) *	2019-02-28	2024-04-16	森永乳業株式会社	発酵乳
CN111529703B (zh) *	2020-06-17	2023-09-15	湖南循天然营养有限公司	一种组合物及其制备方法与在制备免疫佐剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4954622A (en) *	1985-10-31	1990-09-04	The Australian National University	Pharmaceutical composition and method containing gamma inulin or derivative thereof
US5422346A (en) *	1988-01-06	1995-06-06	California Natural Products	Instant dried dahlia inulin juice and its method of production and usage
DE4341780A1 (de) *	1993-12-08	1995-06-14	Suedzucker Ag	Hydrierte Fructooligosaccharide
DE69520528T2 (de) *	1994-06-14	2001-09-27	Raffinerie Tirlemontoise, S.A.	Verwendung einer Zusammensetzung enthaltend Inulin oder Oligofructose als Antikrebsmittel
ATE169456T1 (de) *	1996-12-23	1998-08-15	Sitia Yomo Spa	Lyophilisierte, lebende bakerien enthaltende nahrungszusammensetzung
US6203797B1 (en) *	1998-01-06	2001-03-20	Stephen C. Perry	Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome

2001
- 2001-02-14 PL PL01365136A patent/PL365136A1/xx unknown
- 2001-02-14 KR KR1020027011308A patent/KR20020081375A/ko not_active Ceased
- 2001-02-14 JP JP2001563122A patent/JP4838477B2/ja not_active Expired - Fee Related
- 2001-02-14 PT PT01903767T patent/PT1261355E/pt unknown
- 2001-02-14 HU HU0204546A patent/HUP0204546A3/hu unknown
- 2001-02-14 BR BR0108828-9A patent/BR0108828A/pt not_active Application Discontinuation
- 2001-02-14 CA CA2400969A patent/CA2400969C/fr not_active Expired - Fee Related
- 2001-02-14 WO PCT/EP2001/001627 patent/WO2001064225A1/fr active IP Right Grant
- 2001-02-14 AT AT01903767T patent/ATE283697T1/de not_active IP Right Cessation
- 2001-02-14 MX MXPA02008447A patent/MXPA02008447A/es active IP Right Grant
- 2001-02-14 AU AU2001231746A patent/AU2001231746C1/en not_active Ceased
- 2001-02-14 DE DE60107544T patent/DE60107544T2/de not_active Expired - Lifetime
- 2001-02-14 UA UA2002097766A patent/UA73763C2/uk unknown
- 2001-02-14 IL IL15128001A patent/IL151280A0/xx unknown
- 2001-02-14 AU AU3174601A patent/AU3174601A/xx active Pending
- 2001-02-14 EP EP01903767A patent/EP1261355B1/fr not_active Expired - Lifetime
- 2001-02-14 CN CNB018058973A patent/CN1243551C/zh not_active Expired - Fee Related
- 2001-02-14 ES ES01903767T patent/ES2232591T3/es not_active Expired - Lifetime
- 2001-03-01 AR ARP010100985A patent/AR027968A1/es not_active Application Discontinuation
2002
- 2002-08-22 NO NO20024011A patent/NO20024011D0/no unknown
- 2002-08-26 US US10/228,722 patent/US20030040492A1/en not_active Abandoned
- 2002-09-30 ZA ZA200207849A patent/ZA200207849B/en unknown
2004
- 2004-04-13 US US10/822,799 patent/US7101553B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7101553B2 (en)	2006-09-05
HUP0204546A3 (en)	2003-10-28
CA2400969A1 (fr)	2001-09-07
JP2003533438A (ja)	2003-11-11
ES2232591T3 (es)	2005-06-01
ATE283697T1 (de)	2004-12-15
US20040191234A1 (en)	2004-09-30
DE60107544D1 (de)	2005-01-05
PL365136A1 (en)	2004-12-27
CN1422158A (zh)	2003-06-04
DE60107544T2 (de)	2005-12-15
CA2400969C (fr)	2011-04-19
BR0108828A (pt)	2002-12-10
UA73763C2 (en)	2005-09-15
HUP0204546A2 (en)	2003-05-28
AU2001231746B2 (en)	2004-12-23
AR027968A1 (es)	2003-04-16
AU3174601A (en)	2001-09-12
HK1051650A1 (en)	2003-08-15
EP1261355B1 (fr)	2004-12-01
EP1261355A1 (fr)	2002-12-04
US20030040492A1 (en)	2003-02-27
KR20020081375A (ko)	2002-10-26
IL151280A0 (en)	2003-04-10
PT1261355E (pt)	2005-02-28
AU2001231746C1 (en)	2005-10-06
JP4838477B2 (ja)	2011-12-14
NO20024011D0 (no)	2002-08-22
WO2001064225A1 (fr)	2001-09-07
CN1243551C (zh)	2006-03-01
ZA200207849B (en)	2003-12-30
MXPA02008447A (es)	2002-12-13

Publication	Publication Date	Title
NO20024011L (no)	2002-08-22	Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret
SG152270A1 (en)	2009-05-29	Immunemodulating oligosaccharides
WO2005055934A3 (fr)	2009-04-16	Procedes de gestion alimentaire du syndrome du colon irritable et de la malabsorption des glucides
NO20072906L (no)	2007-06-07	Metode for forhindring eller behandling av respiratoriske infeksjoner og akutt otitis media hos barn
NO20072733L (no)	2007-05-29	Doseformer
DE69936740D1 (de)	2007-09-13	Oligosaccharide und Probiotica enthaltendes Präparat
WO2007002836A3 (fr)	2008-09-12	Procedes et compositions pour la prevention et le traitement de maladie renale
SE9404196D0 (sv)	1994-12-02	New antithrombotic formulation
NO20060498L (no)	2006-02-24	Metode for a promotere benvekst
NO20023473L (no)	2002-09-23	Sammensetninger for levering av en kortisol antagonist
NO20045240L (no)	2004-11-30	Transepikutan administrasjonsform for a behandle restless legs syndromet
DE602004018944D1 (de)	2009-02-26	Verwendung von abführmittel zur behandlung des reizdarmsyndroms
CA2408541A1 (fr)	2001-11-15	Traitement contre l'eczema et/ou le psoriasis
BRPI0416088A (pt)	2007-01-02	composição, sistema, e método de tratar condições tais como calcificação vascular
NO984760L (no)	1998-10-12	Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
DK1196174T3 (da)	2007-12-27	Diætmæssigt calcium, som et tilskud til D-vitamin-forbindelsesbehandling af multipel sclerose
AU4155700A (en)	2000-10-09	Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
NO985695L (no)	1999-02-04	Formulering og fremgangsmÕte for Õ behandle kongestiv hjerteinfarkt
NO982854D0 (no)	1998-06-19	Nitrogenoksyd (NO) syntetase-inhibitor for Õ behandle eller forebygge type II diabetes
BR0113101A (pt)	2003-06-24	Utilização de um inibidor de lìpases e processo e medicamento oral para tratamento, redução ou prevenção de dispepsia funcional
MY127741A (en)	2006-12-29	Wash-off vitamin e compositions
BR9507848A (pt)	1997-09-16	Composição farmcéutica contendo espiramicina eventualmente em associação com o metronizadol
WO2003032895A3 (fr)	2005-12-08	Methodes et compositions pharmaceutiques destinees a la stimulation du systeme immunitaire et/ou au traitement du cancer
BR0313046A (pt)	2005-06-14	Uso de inibidores de quimase para prevenção e/ou tratamento de insuficiência de enxerto arteriovenoso
DK0678022T3 (da)	1996-12-02	Anvendelse af riluzol ved fremstilling af lægemidler, som er anvendelige til behandling af stråleskader